A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

Summary

The purpose of this study is to evaluate how well JNJ-89495120 works (anti-depressant effects) and how well it is tolerated as compared to placebo on reducing the symptoms of depression in participants with major depressive disorder (MDD).

Timeline

Start

2024-12-26

Primary completion

2026-06-25

Completion

2026-08-10

Drugs

Indications